KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

Jazz Pharmaceuticals (JAZZ) Receivables - Net (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 16 years of Receivables - Net data on record, last reported at $830.7 million in Q4 2025.

  • For Q4 2025, Receivables - Net rose 15.9% year-over-year to $830.7 million; the TTM value through Dec 2025 reached $830.7 million, up 15.9%, while the annual FY2025 figure was $830.7 million, 15.9% up from the prior year.
  • Receivables - Net reached $830.7 million in Q4 2025 per JAZZ's latest filing, up from $764.4 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $830.7 million in Q4 2025 and bottomed at $414.0 million in Q1 2021.
  • Average Receivables - Net over 5 years is $638.9 million, with a median of $639.7 million recorded in 2022.
  • Peak YoY movement for Receivables - Net: skyrocketed 43.97% in 2021, then decreased 7.65% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $563.4 million in 2021, then grew by 15.64% to $651.5 million in 2022, then rose by 8.33% to $705.8 million in 2023, then increased by 1.55% to $716.8 million in 2024, then rose by 15.9% to $830.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $830.7 million in Q4 2025, $764.4 million in Q3 2025, and $714.0 million in Q2 2025.